Mega menu

Home
Product regulation
Product regulation

Understand your obligations and access industry Guidance and other information about the products we regulate.
Safety and shortages
Safety and shortages

Access information about product recalls, shortages and other alerts, and learn how we manage safety.
Resources and guidance
Resources and guidance

Get information to help you understand our work, regulations and industry obligations.
Business services
Business services

Access our systems to submit applications, manage forms, make payments and communicate securely.

Southern Cross Pharma Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

ARTG (263)
Cancellation by sponsor (205)
Prescription medicine registration (22)
Australian Public Assessment Report (AusPAR) (4)
Prescription medicine decision summary (1)
Section 14, TGO91 consent (1)

Date

2026 (6)
2025 (5)
2024 (16)
2023 (30)
2022 (102)
2021 (29)
2020 (50)
2019 (59)
2018 (35)
2017 (50)
2016 (22)
2015 (17)
2014 (9)
2013 (11)
2012 (19)
2011 (9)
2010 (9)
2009 (13)
2008 (3)
2007 (1)
2003 (1)

Search

Sponsor content

496 result(s) found, displaying 291 to 300

PREGABALIN LUPIN pregabalin 225 mg capsule blister pack (267566)

14 February 2017

ARTG

Australian Register of Therapeutic Goods (ARTG) information for PREGABALIN LUPIN pregabalin 225 mg capsule blister pack.
PREGABALIN LUPIN pregabalin 75 mg capsule blister pack (267562)

14 February 2017

ARTG

Australian Register of Therapeutic Goods (ARTG) information for PREGABALIN LUPIN pregabalin 75 mg capsule blister pack.
PREGABALIN LUPIN pregabalin 100 mg capsule blister pack (267563)

14 February 2017

ARTG

Australian Register of Therapeutic Goods (ARTG) information for PREGABALIN LUPIN pregabalin 100 mg capsule blister pack.
PREGABALIN LUPIN pregabalin 50 mg capsule blister pack (267561)

14 February 2017

ARTG

Australian Register of Therapeutic Goods (ARTG) information for PREGABALIN LUPIN pregabalin 50 mg capsule blister pack.
APO-MESALAZINE MR, MESALAZINE RMB, MESALAZINE SCP, MESALAZINE TLB (Southern Cross Pharma Pty Ltd)

20 December 2019

Prescription medicine registration

Active ingredients: mesalazine.
APO-MESALAZINE MR, MESALAZINE RMB, MESALAZINE SCP, MESALAZINE TLB (Southern Cross Pharma Pty Ltd)

20 December 2019

Prescription medicine registration

Active ingredients: mesalazine.
AusPAR: Cinnarizine / Dimenhydrinate

18 December 2019

Australian Public Assessment Report (AusPAR)

Australian Public Assessment Report for Cinnarizine / Dimenhydrinate
TRANEXAMIC ACID LUPIN tranexamic acid 500 mg tablet bottle (272731)

30 January 2017

ARTG

Australian Register of Therapeutic Goods (ARTG) information for TRANEXAMIC ACID LUPIN tranexamic acid 500 mg tablet bottle.
APO-TRANEXAMIC ACID tranexamic acid 500 mg tablet bottle (272727)

30 January 2017

ARTG

Australian Register of Therapeutic Goods (ARTG) information for APO-TRANEXAMIC ACID tranexamic acid 500 mg tablet bottle.
TRANEXAMIC ACID LUPIN tranexamic acid 500 mg tablet blister pack (272729)

30 January 2017

ARTG

Australian Register of Therapeutic Goods (ARTG) information for TRANEXAMIC ACID LUPIN tranexamic acid 500 mg tablet blister pack.

Pages

First page
Previous page
…
Page 26
Page 27
Page 28
Page 29
Current page 30
Page 31
Page 32
Page 33
Page 34
…
Next page
Last page

Using our website

Accessibility
Privacy
Security
Disclaimer
Copyright
Freedom of information
Acronyms and glossary terms

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Email subscriptions
Contact us
Facebook
(formerly Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health, Disability and Ageing acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.